中国医疗网络(00383.HK)年度业绩由亏转盈3661万港元
格隆汇8月29日丨中国医疗网络(00383.HK)发布公告,截至2019年6月30日止12个月,公司收入11.96亿港元,同比增长8.6%;期间溢利3661万港元,上年同期亏损1.48亿港元;每股盈利0.24港仙。
由亏转盈乃主要由于(i)医疗分部复医院费用及收费增加;(ii)放债服务的利息收入增加;(iii)相较2018年录得亏损,持作买卖分投资公允价值变动录得收益;(iv)融资成本减少;及(v)整体税项拨回。
期间本集团透过其全资拥有附属公司同仁医疗产业集团有限公司营运医疗分部,分别录得增长收入1,043,363,000港元(2018年:964,563,000港元)及溢利18,733,000港元(2018年:5,226,000港元)。未计利息、税项、折旧及摊销,期间医疗分部产生EBITDA139,551,000港元(2018年:130,387,000港元)。于回顾期间内,医疗分部已实施重组措施,以精简及平整其管理架构旨在加强沟通及效率,并且减低其公司营运开支。
期间集团护老分部透过营运其全资拥有附属公司Aveo China (Holdings) Limited,录得收入105,280,000港元(2018年:100,753,000港元)及亏损下跌20,903,000港元(2018年:58,154,000港元),此乃因为并无投资物业的公允价值变动亏损(2018年:18,632,000港元)。为致力改善其财务表现,护老分部自2018年下半年起开始实施一系列成本减省及重组措施,藉以减低其营运开支及重整其业务运作及管理架构。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.